2017-2018 Session
Change SessionS.92 (Act 193)
An act relating to prescription drug price transparency and cost containment
- Sponsor(s)
- Last Recorded Action
- Senate 5/12/2018 - Signed by Governor on May 30, 2018
Bill/Resolution Text
- Other Text
-
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to prescription drug price transparency and cost containment
Detailed Status
2017-2018 Legislative Session
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to prescription drug price transparency and cost containment
Roll Call History
2017-2018 Legislative Session
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to prescription drug price transparency and cost containment
Committee Meetings
2017-2018 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to prescription drug price transparency and cost containment
Meeting Full List
2017-2018 Legislative Session
Thursday, March 2, 2017
- Committee(s):
- Senate Committee on Health and Welfare
- 11:00 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Charles Storrow, Express Scripts, Inc.
Bonita Libman, Professor of Medicine, University of Vermont Medical Center
Jessa Barnard, General Counsel and Vice-President for Policy, Vermont Medical Society
Thomas Felix, Medical Director, R& D Policy, Amgen
Tuesday, March 14, 2017
- Committee(s):
- Senate Committee on Health and Welfare
- -
-
S.92 - An act relating to prescription drug price transparency and cost containment
Jason Williams, Director of Government and Community Relations, University of Vermont Medical Center
Wednesday, March 15, 2017
- Committee(s):
- Senate Committee on Health and Welfare
- 10:15 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, March 17, 2017
- Committee(s):
- Senate Committee on Health and Welfare
- 8:00 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Vote
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, March 30, 2017
- Committee(s):
- House Committee on Health Care
- 3:15 PM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Walk-through
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, March 16, 2018
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Tuesday, April 3, 2018
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Jessa Barnard, Executive Director, Vermont Medical Society
Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Jim McKay, Director of Clinical Development and Medical Affairs, Sandoz
Carrie Phillips, Executive Officer, Vermont Board of Pharmacy
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Friday, April 13, 2018
- Committee(s):
- House Committee on Health Care
- 1:40 PM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Review new draft of bill and vote
Rep. Lori Houghton
Rep. Benjamin Jickling, House Committee on Health Care
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 20, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Review House Amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, April 25, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 8:30 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Rep. Lori Houghton, House Committee on Health Care
Rep. William J. Lippert, House Committee on Health Care
Jeff Hochberg, President, Vermont Retail Druggists
Jamie Feehan, Lobbyist, CVS/Caremark
Bridget Morris, Lobbyist, Association of Accessible Medicine
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
- 10:00 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Continued Testimony and Committee Discussion
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Jeff Hochberg, President, Vermont Retail Druggists
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Thursday, April 26, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 8:30 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Proposed Amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jamie Feehan, Lobbyist, CVS/Caremark
Rep. Lori Houghton, House Committee on Health Care
Thursday, April 26, 2018
- Committee(s):
- House Committee on Health Care
- 9:40 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Update, Senate actions
Rep. Lori Houghton
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 27, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:30 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Proposed Amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, May 2, 2018
- Committee(s):
- House Committee on Health Care
- 10:00 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Committee discussion, changes to various bills from the Senate; others as needed
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, May 3, 2018
- Committee(s):
- House Committee on Health Care
- 9:30 AM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Review changes; other bills as needed
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Stephanie Barrett, Associate Fiscal Officer, Joint Fiscal Office
- 1:00 PM
-
S.92 - An act relating to prescription drug price transparency and cost containment
Committee Discussion; further amendment to S.203; vote on S.224.
Committee Documents
An act relating to prescription drug price transparency and cost containment
Witnesses Who Testified
2017-2018 Legislative Session
House Committee on Health Care
- Jessa Barnard, Executive Director, Vermont Medical Society
- Stephanie Barrett, Associate Fiscal Officer, Joint Fiscal Office
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Rep. Lori Houghton
- Rep. Benjamin Jickling, House Committee on Health Care
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Jim McKay, Director of Clinical Development and Medical Affairs, Sandoz
- Matt McMahon, Lobbyist, McLean, Meehan & Rice
- Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
- Carrie Phillips, Executive Officer, Vermont Board of Pharmacy
Senate Committee on Health and Welfare
- Jessa Barnard, General Counsel and Vice-President for Policy, Vermont Medical Society
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Jamie Feehan, Lobbyist, CVS/Caremark
- Thomas Felix, Medical Director, R& D Policy, Amgen
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Jeff Hochberg, President, Vermont Retail Druggists
- Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
- Rep. Lori Houghton, House Committee on Health Care
- Bonita Libman, Professor of Medicine, University of Vermont Medical Center
- Rep. William J. Lippert, House Committee on Health Care
- Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
- Matt McMahon, Lobbyist, McLean, Meehan & Rice
- Bridget Morris, Lobbyist, Association of Accessible Medicine
- Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
- Charles Storrow, Express Scripts, Inc.
- Jason Williams, Director of Government and Community Relations, University of Vermont Medical Center
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for S.92 in the 2017-2018 Legislative Session.
No committee of conference members found for S.92 in the 2017-2018 Legislative Session.
An act relating to prescription drug price transparency and cost containment
Committee of Conference Meetings
2017-2018 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to prescription drug price transparency and cost containment
Committee of Conference Meeting Full List
2017-2018 Legislative Session
No committee of conference meeting history found for S.92 in the 2017-2018 Legislative Session.
No committee of conference report found for S.92 in the 2017-2018 Legislative Session.
Act
- Signed into law 5/30/2018
- As Enacted (ACT 193)
- Act Summary
An act relating to prescription drug price transparency and cost containment
Statutes Affected
2017-2018 Legislative Session
| Statute |
|---|
| 8 V.S.A. § 4062. Filing and approval of policy forms and premiums |
| 8 V.S.A. § 4089i. Prescription drug coverage |
| 18 V.S.A. § 4601. Definitions |
| 18 V.S.A. § 4605. Alternative drug or biological product selection |
| 18 V.S.A. § 4606. Brand certification |
| 18 V.S.A. § 4607. Information; labeling |
| 18 V.S.A. § 4608. Liability |
| 18 V.S.A. § 4635. Prescription drug cost transparency |
| 18 V.S.A. § 4636. Impact of prescription drug costs on health insurance premiums; report |
| 18 V.S.A. § 4637. Notice of introduction of new high-cost prescription drugs |
| 18 V.S.A. § 9473. Pharmacy benefit managers; required practices with respect to pharmacies |
